coming up, my interview with the c or fo of johnson & johnson, joe wolk is here, the drugmaker haltingaccine trials earlier in the week. i'll is ask him about that and the company's quarterly outlook. then later, i'll speak with ceo john mackey on the rise of online grocery shopping and where retail heads next. but first, let's take a look back at some of the week's big moments in this week's edition of "the week's talkers." watch. ♪ ♪ maria: you have a scenario that you believe took place here. tell us what you see. >> oh, definitely. they framed general flynn because he was the cornerstone of the insurance policy to destroy president trump in the event he was elected. maria: you've been talking about this, something was to come, for some time. >> if you take a look at this hard drive and you're an fbi agent, you're compelled to do something about it because there are things on it that haven't come out yet that if any fbi agent sat by and watched it, they shouldn't be an fbi agent. maria: the fbi was leaking stories to web sites, and then they would use those stories that they leaked

joining me rights now is the cfo and executive vice president of johnson & johnson, joe wolk. his morning. thanks very much for joining us. >> good morning, maria. pleasure to be here. congratulations on the pending release of your new book. maria: thank you so much. what can you tell us about the breaking news, first? i want to get into the quarter and what drove business in the last quarter, of course, how j&j is allocating its capital and where your priorities are but the news of the day is this situation in terms of the vaccine and this halt. when do you expect to resume the trial? >> so, maria, we're letting the drug safety monitoring board kind of go through their analysis. we learned about this event, singular event within the last 36 hours. it should really reassure the public that all scientific, medical and ethical protocols are being followed to the utmost degree and we have to let the process play out, let that information be analyzed by the independent board and we'll proceed accordingly. again, we've had 100,000 patients on this platform through other means with e

i spoke with the cfo and executive vice president joe wolk on the news of the trials and what's ahead safety monitoring board kind of go through their analysis. we've learned about this event, singular event, within the last 36 hours. it should really reassure the public that all scientific, medical and ethical protocols are being followed to the utmost degree. and we just have to let that process play out, are let that information be analyzed by the independent board, and we'll proceed accordingly. again, we've had 100,000 finish. maria: understood -- >> -- patients on this platform through other means we ebola, h user e v, zika, and so we have a high degree of confidence in the safety of this, but we want to make sure we're thorough for this unexpected event. maria: understood. you have to make allowances for the situation where people might actually have an adverse reaction, i get that. but does this in any way suggest that you are having less confidence in a vaccine the way you were quite confident just six months ago of having a vaccine out in the market within the next year? >>

coming up, my interview with the c or fo of johnson & johnson, joe wolk is here, the drugmaker halting i'll is ask him about that and the company's quarterly outlook. then later, i'll speak with ceo john mackey on the rise of online grocery shopping and where retail heads next. but first,

coming up, my interview with the c or fo of johnson & johnson, joe wolk is here, the drugmaker haltingt and the company's quarterly outlook. then later, i'll speak with ceo john mackey on the rise of online grocery shopping and where retail heads next. but first,

coming up, my interview with the c or fo of johnson & johnson, joe wolk is here, the drugmaker haltingthe company's quarterly outlook. then later, i'll speak with ceo john mackey on the rise of online grocery shopping and where retail heads next. but

anyway, thank you, joe wolk.arry fink, what he has to say about the latest quarter, the state of the economy, the election and more and z.zeke emanuel discussing what we need to do as we head into colder weather. one would be wear a sweater would be a bit of advice you're watching "squawk box" on cnbc after my dvt blood clot... i wondered.. could another come around the corner? or could it play out differently? i wanted to help protect myself. my doctor recommended eliquis. eliquis is proven to treat and help prevent another dvt or pe blood clot. almost 98 percent of patients on eliquis didn't experience another. -and eliquis has significantly less major bleeding than the standard treatment. eliquis is fda-approved and has both. don't stop eliquis unless your doctor tells you to. eliquis can cause serious and in rare cases fatal bleeding. don't take eliquis if you have an artificial heart valve or abnormal bleeding. if you had a spinal injection while on eliquis call your doctor right away if you have tingling, n